These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2144760)

  • 1. Mitoxantrone in advanced and/or recurrent endometrial carcinoma.
    Veenhof KH; George M; Forni M; Tumolo S; Rotmensz N; Vermorken JB
    Eur J Cancer; 1990; 26(5):650. PubMed ID: 2144760
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of mitoxantrone in advanced or metastatic endometrial carcinoma.
    Boadle DJ; Tattersall MH
    Aust N Z J Obstet Gynaecol; 1987 Nov; 27(4):341-2. PubMed ID: 3453676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitoxantrone therapy of advanced adenocarcinoma of the endometrium. A phase II trial.
    Runge HM; Meerpohl HG; Pfleiderer A
    Onkologie; 1989 Apr; 12(2):102-3. PubMed ID: 2660047
    [No Abstract]   [Full Text] [Related]  

  • 4. Mitoxantrone for carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group.
    Muss HB; Bundy BN; DiSaia PJ; Ehrlich CE
    Cancer Treat Rep; 1987 Feb; 71(2):217-8. PubMed ID: 3802120
    [No Abstract]   [Full Text] [Related]  

  • 5. Mitoxantrone in adenocarcinoma of the endometrium: a Southwest Oncology Group Study.
    Hilgers RD; Von Hoff DD; Stephens RL; Boutselis JG; Rivkin SE
    Cancer Treat Rep; 1985 Nov; 69(11):1329-30. PubMed ID: 4092197
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II evaluation of carboplatin in advanced endometrial carcinoma.
    Long HJ; Pfeifle DM; Wieand HS; Krook JE; Edmonson JH; Buckner JC
    J Natl Cancer Inst; 1988 Apr; 80(4):276-8. PubMed ID: 3280811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study.
    Stehman FB; Blessing JA; Delgado G; Louka M
    Cancer Treat Rep; 1983; 67(7-8):737-8. PubMed ID: 6871892
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study.
    Slavik M; Petty WM; Blessing JA; Creasman WT; Homesley HD
    Cancer Treat Rep; 1984 May; 68(5):809-11. PubMed ID: 6722836
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effective progestogen therapy of endometrial hyperplasia and adenocarcinoma by administration of a combined progestogen-estrogen preparation].
    Miyawaki Y; Ueki M; Sugimoto O
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2598-605. PubMed ID: 3209928
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitoxantrone in advanced cervical carcinoma: a phase II study in patients not previously treated with chemotherapy.
    Hørding U; Rose C; Jakobsen K; Dirksen H
    Cancer Treat Rep; 1986 Oct; 70(10):1239-40. PubMed ID: 3756944
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of mitoxantrone in advanced gastric cancer.
    Goldenberg A; Kelsen D; Benedetto P
    Oncology; 1988; 45(4):273-5. PubMed ID: 3290754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of advanced and recurrent endometrial carcinoma with cyclophosphamide, doxorubicin, 5-fluorouracil, and megestrol acetate.
    Deppe G; Jacobs AJ; Bruckner H; Cohen CJ
    Am J Obstet Gynecol; 1981 Jun; 140(3):313-6. PubMed ID: 7246635
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonhormonal chemotherapy of endometrial adenocarcinoma: a review.
    Donovan JF
    Cancer; 1974 Nov; 34(5):1587-92. PubMed ID: 4609594
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II evaluation of mitoxantrone in advanced non anaplastic thyroid cancer.
    Schlumberger M; Parmentier C
    Bull Cancer; 1989; 76(4):403-6. PubMed ID: 2752182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of advanced endometrial adenocarcinoma with tamoxifen.
    Swenerton KD
    Cancer Treat Rep; 1980; 64(6-7):805-11. PubMed ID: 7427965
    [No Abstract]   [Full Text] [Related]  

  • 16. [Histological changes observed in the treatment of endometrial glandular epithelioma with lynestrenol].
    Lejeune B; Wilkin P
    J Gynecol Obstet Biol Reprod (Paris); 1977 Dec; 6(8):1159-69. PubMed ID: 608932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy in the management of advanced or recurrent cervical and endometrial carcinoma.
    Thigpen T; Vance RB; Balducci L; Blessing J
    Cancer; 1981 Jul; 48(2 Suppl):658-65. PubMed ID: 7023669
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of advanced endometrial adenocarcinoma with cis-dichlorodiammine platinum (II) after intensive prior therapy.
    Deppe G; Cohen CJ; Bruckner HW
    Gynecol Oncol; 1980 Aug; 10(1):51-4. PubMed ID: 7190531
    [No Abstract]   [Full Text] [Related]  

  • 19. Tamoxifen flare in advanced endometrial carcinoma.
    Brooks BJ; Lippman ME
    J Clin Oncol; 1985 Feb; 3(2):222-3. PubMed ID: 2578557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia.
    Carlson JA; Allegra JC; Day TG; Wittliff JL
    Am J Obstet Gynecol; 1984 May; 149(2):149-53. PubMed ID: 6232850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.